PRETENOL

This brand name is authorized in Nigeria.

Active ingredients

The drug PRETENOL contains one active pharmaceutical ingredient (API):

1
UNII 50VV3VW0TI - ATENOLOL
 

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

 
Read more about Atenolol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-8161 Tablet ATENOLOL-100 TABLET TAB 100 mg 2X14 31 RNW-PP-310316 31 RNW-PP-310316 ATENOLOL-100 TABLET ATENOLOL BP 100MG Atenolol BP 100mg and q.s. B4-8161 Drugs Imported Products 214 POM 1 1/28/2023 CHEZ RESOURCES PHARMACEUTICAL LIMITED, 7 CALABAR STREET FEGGE ONITSHA ANAMBRA 46485780 chezrespharm@gmail.com ALPA LABORATORIES LTD, 33/2, PIGDAMBER A.B. ROAD-453 446 DISTT. INDORE-(M.P.) INDIA, India ATENOLOL BP 100MG Atenolol BP 100mg and q.s. B4-8161 Drugs Imported Products 214 POM 1 1/28/2023 CHEZ RESOURCES PHARMACEUTICAL LIMITED, 7 CALABAR STREET FEGGE ONITSHA ANAMBRA 46485780 chezrespharm@gmail.com ALPA LABORATORIES LTD, 33/2, PIGDAMBER A.B. ROAD-453 446 DISTT. INDORE-(M.P.) INDIA, India 25/05/2023
B4-8238 Tablet ATENOLOL-50MG TABLET TAB 50 mg 2X14 32 RNW-PP-310298 ATENOLOL-50MG TABLET ATENOLOL BP 50MG Atenolol BP 50mg and q.s. B4-8238 Drugs Imported Products 214tablets Prescription Only Medicine (POM) 1/28/2023 CHEZ RESOURCES PHARMACEUTICAL LIMITED, 7 CALABAR STREET FEGGE ONITSHA ANAMBRA 46485780 chezrespharm@gmail.com ALPA LABORATORIES LTD, 33/2, PIGDAMBER A.B. ROAD-453 446 DISTT. INDORE-(M.P.) INDIA, India 25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C07AB03 Atenolol C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-8161, B4-8238

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.